Many cannabis consumers have experienced the infamous red eye. The eyes are often the most common giveaway after a serious session with a vaporizer.
Yet, while some may find the herb’s visible effects on the eyes to be burdensome, there are several surprising ways that cannabis supports ocular health.
From easing symptoms of eye disease to staving off degenerative blindness, here’s what you need to know about how cannabis affects the eyes:
How does cannabis affect the eyes?
As it turns out, cannabis may help you see things a little differently. Research suggests that the herb can have an impact on every organ in the body, including the eyes.
While it may sound too good to be true, cannabis compounds work their magic in the eyes by tapping into one of the largest cellular communication networks in vertebrates. This network is the endocannabinoid system (ECS).
Cannabis compounds interact with the ECS by engaging a special type of cell receptor, called a cannabinoid receptor.
The human eye happens to express high levels of one particular cannabinoid receptor, the CB1. Vision processing centers of the brain also feature a bounty of these landing sites.
In addition, preclinical investigations suggest that the ECS plays a crucial role in our vision.
A 2016 primate study published in Neural Plasticity has found that manipulating cannabinoid receptors changes the way electroretinographic waves pass through the retina.
These waves are measured by an electroretinogram, which records the electrical response of the eye to a light stimulus. The researchers found that cannabinoid receptors moderated the eye’s response to light.
The ways in which cannabis affects eyesight needs further investigation. However, this early research offers even more reason to investigate cannabis as a treatment for diseases of the eye.
Already, there are several acute ways that cannabis affects the eyes. While some are spectacular, like improved night vision, not all of the effects are enjoyable. Shortly after consuming the herb, it is not uncommon to experience:
- Red Eye
Red eyes are not always the favorite cannabis side effect. While red eyes may be a tell-tale giveaway that you’ve consumed a little cannabis, those who experience tension around the eye might appreciate the relaxing effects of the herb.
Cannabis lowers blood pressure. This causes capillaries and blood vessels to dilate, leading to what is commonly referred to as red eye.
Wider capillaries mean blood flows into the eyes, reducing intraocular pressure. In a way, this a form of relaxation for the eyes. This could be beneficial for patients with painful ocular conditions like glaucoma.
- Allergy
It’s not uncommon for some people to experience an allergic reaction in the eyes after smoking cannabis. This reaction can be triggered by an allergy to smoke, residual molds, or the cannabis plant itself.
Signs of allergy typically include itchiness, redness, inflammation, tearing, and dryness.
In 2015, research from the American College of Allergy, Asthma, and Immunology suggests that cannabis allergy is similar to Hay Fever, causing eye irritation and an itchy nose for those exposed to smoke, pollen, or plant material.
- Enhanced night vision
Laboratory research like that mentioned above has found that cannabinoid receptors seem to help the eyes respond to light.
Additional research from 2016 suggests that cannabis compounds, like psychoactive THC, connect with these receptors. Engaging these receptors is thought to improve the ability to see in low-light conditions.
For the past three decades, researchers have speculated that cannabis may also improve night vision. In the 1990s, M.E. West, a pharmacologist, noticed that Jamaican fishermen who consumed a cannabis elixir had an “uncanny ability to see in the dark.”
A small study conducted in 2004 tested the effects of traditional cannabis Kif and a synthetic THC in three Moroccan individuals. Kif is a mixture of cannabis and tobacco. This small experiment found a dose-dependent relationship between cannabis consumption and improved night vision.
- Visual processing
Interestingly, recent evidence suggests that the endocannabinoid system contributes to visual development in the brain.
A study from University of Waterloo, University of Auckland and Brown University found that babies exposed to cannabis in utero scored significantly higher in visual processing tests.
While babies exposed to alcohol scored lower in visual processing tests, those exposed to cannabis had improved global motion perception.
This is certainly not a reason to consume cannabis during pregnancy, but these findings do add fuel to the idea that cannabinoids and the ECS help the eyes and brain make sense of visual information.
Cannabis and eye disease
Cannabis affects the eyes in a variety of different ways.
While there is still much to discover about cannabis and eye health, a growing body of evidence suggests that the herb may be useful in a number of diseases of the eye.
Some of these diseases include:
- Glaucoma
The notorious red eye that cannabis causes may also be the reason the herb is thought to be so helpful for glaucoma patients. Glaucoma is a disease that damages the optic nerve, and it is considered one of the leading causes of blindness in the world.
Researchers have been studying the effects of cannabis on glaucoma since as early as the 1970s. In one experiment with 16 human participants, inhaled cannabis successfully reduced the intraocular pressure that contributes to pain and degeneration with this disease.
Patients felt relief for a total of three to four hours after cannabis treatment. Patients with high blood pressure and glaucoma experienced the longest and most significant results. Research from 1980 and 2000 corroborate these findings.
- Neurodegenerative blindness
In 2014, research published in Experimental Eye Research suggested that cannabis medicines may be able to slow down degenerative blindness. Specifically, cannabis compounds prevented the death of photoreceptors in those with retinitis pigmentosa.
The research used rodents as test subjects. Rats were treated with a synthetic cannabinoid over the course of 90 days. After the three months were up, the scientists checked on the progression of their blindness.
Rats treated with the cannabinoid had an impressive 40 percent more photoreceptors than their nontreated counterparts. This is strong evidence that cannabis-like therapies can slow down ocular degeneration in neurodegenerative blindness.
Studies in other areas have found that the herb contains powerful neuroprotective antioxidants, which may lend a hand in a variety of age-associated conditions, not just poor eyesight.
- Diabetic retinopathy
A 2006 preclinical study found that cannabidiol (CBD), a cannabis compound that does not cause a psychotropic “high”, may help protect the eyes of diabetics.
Diabetic retinopathy is a side effect of diabetes and it causes damage to the blood vessels in the retina. The retina is the light-sensitive part of the eye. In diabetic retinopathy, the nerve cells in the eye begin to die, which directly affects eyesight.
As a potent antioxidant, researchers believe that CBD can check back some of the toxicity in the retina that contributes to degeneration.
A study claiming chronic cannabis consumption damages the retina has recently made headlines across the net. Yet, this 2006 research suggests that some cannabis compounds may actually protect the retina from damage. Perhaps it just depends on how you use the herb.
– This article was originally posted at Green Flower
About CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.cannabisnewswire.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer
Do you have a questions or are you interested in working with CNW? Ask our Editor
CannabisNewsWire (CNW)
Denver, Colorado
www.cannabisnewswire.com
303.498.7722 Office
Editor@CannabisNewsWire.com
This article contains Third-Party Content submitted by third parties, including articles submitted through the CNW Premium Partnership Program. All opinions, statements and representations expressed by such third parties are theirs alone and do not express or represent the views and opinions of CNW or its affiliates and owners. Content created by third parties is the sole responsibility of such third parties, and CNW does not endorse, guarantee or make representations concerning the accuracy and completeness of all third-party content. You acknowledge that by CNW providing you with this internet portal that makes accessible to you the ability to view third-party content through the CNW site, CNW does not undertake any obligation to you as a reader of such content or assume any liability relating to such third-party content. CNW expressly disclaims liability relating to such third-party content. CNW and its members, affiliates, successors, assigns, officers, directors, and partners assume no responsibility or liability that may arise from the third-party content, including, but not limited to, responsibility or liability for claims for defamation, libel, slander, infringement, invasion of privacy and publicity rights, fraud, or misrepresentation, or an private right of action under the federal securities laws of the United States or common law. Notwithstanding the foregoing, CNW reserves the right to remove third-party content at any time in its sole discretion.
